Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP537007.RAIV6Pl-e01kSxKjG7l6i6hyAqqC21DMIE2-Xl4NLbNtE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP537007.RAIV6Pl-e01kSxKjG7l6i6hyAqqC21DMIE2-Xl4NLbNtE130_assertion type Assertion NP537007.RAIV6Pl-e01kSxKjG7l6i6hyAqqC21DMIE2-Xl4NLbNtE130_head.
- NP537007.RAIV6Pl-e01kSxKjG7l6i6hyAqqC21DMIE2-Xl4NLbNtE130_assertion wasGeneratedBy ECO_0000203 NP537007.RAIV6Pl-e01kSxKjG7l6i6hyAqqC21DMIE2-Xl4NLbNtE130_provenance.
- NP537007.RAIV6Pl-e01kSxKjG7l6i6hyAqqC21DMIE2-Xl4NLbNtE130_assertion wasDerivedFrom befree-20150227 NP537007.RAIV6Pl-e01kSxKjG7l6i6hyAqqC21DMIE2-Xl4NLbNtE130_provenance.
- NP537007.RAIV6Pl-e01kSxKjG7l6i6hyAqqC21DMIE2-Xl4NLbNtE130_assertion SIO_000772 16928730 NP537007.RAIV6Pl-e01kSxKjG7l6i6hyAqqC21DMIE2-Xl4NLbNtE130_provenance.
- NP537007.RAIV6Pl-e01kSxKjG7l6i6hyAqqC21DMIE2-Xl4NLbNtE130_assertion evidence source_evidence_literature NP537007.RAIV6Pl-e01kSxKjG7l6i6hyAqqC21DMIE2-Xl4NLbNtE130_provenance.
- NP537007.RAIV6Pl-e01kSxKjG7l6i6hyAqqC21DMIE2-Xl4NLbNtE130_assertion description "[In the group with the lowest risk of overt nephropathy (n = 340), the ACE D polymorphism increased overt nephropathy risk twofold (p = 0.05), whereas a protective effect was observed for the LIPC CC genotype (p < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP537007.RAIV6Pl-e01kSxKjG7l6i6hyAqqC21DMIE2-Xl4NLbNtE130_provenance.